Robots take on kidney transplants: could they cut complications?

NCT ID NCT05730257

First seen Jan 06, 2026 · Last updated Jun 23, 2026 · Updated 27 times

Summary

This study compares robot-assisted kidney transplant to the standard open surgery in 106 adults with end-stage kidney disease. The goal is to see if the robotic approach reduces serious complications like bleeding or blood clots within 30 days after surgery. Participants are randomly assigned to one of the two procedures and followed for recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Department of Nephrology, Rigshospitalet

    Copenhagen, Ø, 2100, Denmark

  • Urological Research Unit, Rigshospitalet

    Copenhagen, N, 2200, Denmark

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Robot-assisted kidney transplantation (surgical procedure using the DaVinci robot)

What this could lead to

If successful, robot-assisted kidney transplantation could become a standard option that lowers the risk of serious complications like bleeding or blood clots after surgery.

What could go wrong

This is a relatively small trial (106 participants) and results may not apply to all patients. The robotic approach requires special equipment and a trained team, which may limit its use.

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.